A detailed history of Savoie Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Savoie Capital LLC holds 18,216 shares of LLY stock, worth $13.6 Million. This represents 1.97% of its overall portfolio holdings.

Number of Shares
18,216
Previous 16,916 7.69%
Holding current value
$13.6 Million
Previous $15.3 Billion 5.37%
% of portfolio
1.97%
Previous 1.98%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $1 Million - $1.25 Million
1,300 Added 7.69%
18,216 $16.1 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $12.3 Million - $15.4 Million
16,916 New
16,916 $15.3 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $1.62 Million - $1.91 Million
3,084 Added 44.59%
10,000 $5.83 Billion
Q3 2023

Nov 17, 2023

BUY
$434.7 - $599.3 $3.01 Million - $4.14 Million
6,916 New
6,916 $3.71 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Savoie Capital LLC Portfolio

Follow Savoie Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savoie Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savoie Capital LLC with notifications on news.